"The drug, a manufactured antibody that attacks interleukin-11, is being trialled in patients with lung fibrosis. This is where the lungs become scarred, making it harder to breathe."
Hope the trial is successful.
"The drug, a manufactured antibody that attacks interleukin-11, is being trialled in patients with lung fibrosis. This is where the lungs become scarred, making it harder to breathe."
Hope the trial is successful.
Story time. Let me tell you about my first job out of college.
This is what happened when Kaplan University exploited its employees & students.
I’m running for Congress in #IL11 to stop this & make college affordable once again.
Donate and help me win: https://secure.actblue.com/donate/newleadershipforil11